## Clinical Presentation Analysis **Key Point:** The combination of severe hypertriglyceridemia (>1000 mg/dL), recurrent acute pancreatitis, eruptive xanthomas, and inability to calculate LDL by Friedewald formula (due to extremely high triglycerides) is pathognomonic for Type I hyperlipoproteinemia. ## Lipoprotein Type I (Familial Chylomicronemia Syndrome) ### Pathophysiology Type I hyperlipoproteinemia results from deficiency of **lipoprotein lipase (LPL)** or its cofactor apoC-II, leading to: 1. Severe accumulation of chylomicrons in blood (even in fasting state) 2. Triglyceride levels often >1000 mg/dL, sometimes >10,000 mg/dL 3. Milky/creamy appearance of plasma (lipemic plasma) 4. Eruptive xanthomas (from lipid deposition in skin) 5. Hepatosplenomegaly (from chylomicron uptake) ### Diagnostic Criteria | Feature | Type I | Type III | Type IV | | --- | --- | --- | --- | | **Triglycerides** | Markedly elevated (>1000) | Moderately elevated (200–500) | Elevated (200–500) | | **Total Cholesterol** | Markedly elevated | Markedly elevated | Mildly elevated | | **HDL** | Low | Low | Low | | **LDL** | Low/normal | Elevated | Normal | | **Friedewald Formula** | Not applicable (TG too high) | Applicable | Applicable | | **Lipoprotein Pattern** | Chylomicrons + VLDL | IDL accumulation | VLDL accumulation | | **Pancreatitis Risk** | **Very high** | Moderate | Moderate | **High-Yield:** Type I is the only hyperlipoproteinemia where LDL cannot be calculated because triglycerides are so high that the Friedewald formula becomes unreliable (formula: LDL = TC − HDL − TG/5). ### Clinical Features of Type I **Key Point:** Recurrent acute pancreatitis is the hallmark complication—pancreatitis occurs when triglycerides exceed 500–1000 mg/dL due to pancreatic lipase inhibition and increased free fatty acids. - **Eruptive xanthomas:** Yellow papules on buttocks, knees, elbows (pathognomonic) - **Lipemia retinalis:** Creamy appearance of retinal vessels - **Hepatosplenomegaly:** From chylomicron accumulation in macrophages - **Abdominal pain:** From recurrent pancreatitis - **Absence of atherosclerosis:** Paradoxically, despite severe lipemia, premature CAD is NOT a feature (unlike Type IIa) ### Management 1. **Strict fat restriction:** <20 g/day dietary fat (MCT oil preferred) 2. **Fibrates:** Second-line (modest benefit) 3. **Omega-3 fatty acids:** Adjunctive 4. **Avoid:** Alcohol, estrogens (increase VLDL/chylomicrons) 5. **Gene therapy:** Emerging option for LPL deficiency **Clinical Pearl:** Patients with Type I hyperlipoproteinemia paradoxically have LOW risk of atherosclerotic CAD because chylomicrons are not atherogenic; the main threat is pancreatitis. ## Why This Case Is Type I 1. **Fasting triglycerides >1000 mg/dL** → chylomicronemia 2. **Recurrent acute pancreatitis** → classic complication 3. **Eruptive xanthomas** → lipid deposition in skin 4. **Cannot calculate LDL** → triglycerides too high for Friedewald formula 5. **Normal liver/renal function** → excludes secondary causes 6. **No gallstones** → pancreatitis is from lipemia, not biliary obstruction 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.